We are live on
!
Find out more
Cullinan Oncology
CGEM
CGEM
174 hedge funds and large institutions have $931M invested in Cullinan Oncology in 2026 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 61 increasing their positions, 42 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
198% more call options, than puts
Call options by funds: $2.92M | Put options by funds: $978K
135% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 17
45% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 42
42% more capital invested
Capital invested by funds: $654M → $931M (+$277M)
14% more funds holding
Funds holding: 153 → 174 (+21)
1.36% more ownership
Funds ownership: 106.96% → 108.32% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
174
Holders Change
+21
Holders Change %
+13.73%
% of All Funds
2.14%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
40
Increased
61
Reduced
42
Closed
17
Calls
$2.92M
Puts
$978K
Net Calls
+$1.94M
Net Calls Change
-$1.22M
Top Buyers
Top Sellers
| 1 |
AAA
Affinity Asset Advisors
New York
|
-$14.8M |
| 2 |
BOCH
Blue Owl Capital Holdings
New York
|
-$5.67M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$4.29M |
| 4 |
Renaissance Technologies
New York
|
-$3.95M |
| 5 |
Goldman Sachs
New York
|
-$3.42M |
